North America Nucleic Acid Methylation Market Size & Outlook
Related Markets
North America nucleic acid methylation market highlights
- The North America nucleic acid methylation market generated a revenue of USD 1,387.1 million in 2024.
- The market is expected to grow at a CAGR of 4.4% from 2025 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product & services in 2024.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 1,387.1 million |
| Market revenue in 2030 | USD 1,959.5 million |
| Growth rate | 4.4% (CAGR from 2025 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Enzymes, Consumables, Instruments & Software, Services |
Other key industry trends
- In terms of revenue, North America region accounted for 40.5% of the global nucleic acid methylation market in 2024.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,872.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleic Acid Methylation Market Scope
Nucleic Acid Methylation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Diagenode | View profile | 101-250 | Liège, Liege, Belgium, Europe | https://www.diagenode.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Exact Sciences Corp | View profile | 6600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | https://www.exactsciences.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
North America nucleic acid methylation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleic acid methylation market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 39.75% in 2024. Horizon Databook has segmented the North America nucleic acid methylation market based on kits & reagents, enzymes, consumables, instruments & software, services covering the revenue growth of each sub-segment from 2018 to 2030.
In 2024, the North America nucleic acid methylation industry led globally with a 40.46% share, driven by strong investment in biomedical research, advanced healthcare infrastructure, and the widespread adoption of precision medicine.
The region benefits from a high concentration of pharmaceutical and biotechnology companies, extensive funding for epigenetics research, and early adoption of nextgeneration sequencing (NGS) technologies. In addition, increasing regulatory approvals for methylation-based diagnostics and the growing use of liquid biopsy tests further drive market growth in North America.
Reasons to subscribe to North America nucleic acid methylation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America nucleic acid methylation market databook
-
Our clientele includes a mix of nucleic acid methylation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America nucleic acid methylation market , including forecasts for subscribers. This continent databook contains high-level insights into North America nucleic acid methylation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America nucleic acid methylation market size, by country, 2018-2030 (US$M)
North America Nucleic Acid Methylation Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
